PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 323 (xsd:integer)
nif:isString
  • ASD flubendazole was given per os (PO) at 0.2, 0.6, 1.5, 6 or 15 mg/kg for 5 consecutive days, or subcutaneously (SC) at 10 mg/kg one time or for 5 days; control groups were not given any treatment which allowed comparison with both the oral and SC groups rather than having to include 2 different vehicle groups (Table 1).
rdf:type